Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
IRCCS Azienda Ospedaliero-Universitaria di Bologna
Medstar Health Research Institute
AIDS Malignancy Consortium
National Cancer Institute (NCI)